Early Detection for Alzheimer’s/Dementia

30 Jan Early Detection for Alzheimer’s/Dementia

Detect Alzheimer’s & Dementia Risk 10–20 Years in Advance
Cost-Effective & Practical Biomarkers for Early Detection

New laboratory studies have uncovered a groundbreaking way to assess and reduce your risk of Alzheimer’s and dementia. The biggest challenge in reversing these conditions is that they are often diagnosed too late. Now, advanced blood biomarkers can accurately determine your risk, allowing for early intervention—so you may never develop the disease.

Three key blood markers—P-Tau 217, Glial Fibrillary Acidic Protein (GFAP), and Neurofilament Light Chain (NfL)—have been found to be 95% accurate, an exceptionally high standard in medical diagnostics. If elevations in these markers are detected, addressing the underlying factors that contribute to Alzheimer’s and dementia can significantly lower your risk—or even eliminate it altogether. Early detection is essential for prevention and reversal.

Who Should Get Tested?

This test is recommended for:
•  Individuals with a family history of Alzheimer’s, Parkinson’s, or dementia
•  Adults over the age of 40
•  Those with conditions such as diabetes, autoimmune disorders, toxin exposure, chronic brain fog, migraines, or cardiovascular disease

Cost & Consultation

The test is $750, which includes lab analysis, interpretation, and a consultation to develop a personalized strategy for reducing your risk.

Don’t Wait—Early Action is Key!
Know your risk, take control of your health, and prevent Alzheimer’s before it starts. Once symptoms appear, it may be too late to reverse them.